Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis LeVee

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancers|July 12, 2025
Efficacy of Metastasis-Directed Radiation Therapy to Prolong Systemic Therapy for Patients with Oligoprogressive Metastatic Breast CancerAlexis LeVee, Hannah Young, Stephanie Yoon, et al.
The Oncologist|June 23, 2025
Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancerAlexis LeVee, Esther Peluso, Melissa G Lechner, et al.
Cancer Medicine|March 27, 2023
Incidence and prognostic impact of HER2-positivity loss after dual HER2-directed neoadjuvant therapy for HER2+ breast cancerAlexis LeVee, Kellie Spector, Brigid Larkin, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 10, 2026
Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment LandscapeMaeve A Hennessy, Elizabeth Terman, Damé Idossa, et al.
The Oncologist|November 9, 2025
Safety and clinical outcomes of pembrolizumab standard-interval dosing versus extended-interval dosing in patients with breast cancerAlexis LeVee, Austin Kordic, Nora Ruel, et al.
Breast Cancer Research and Treatment|May 28, 2026
Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy: a multi-institution studyAlexis LeVee, Bethania Santos, Megan Wong, et al.
Cancer Treatment and Research|August 23, 2025
Breast Cancer Immunotherapy: A Team Science ApproachMax Duesberg, Alexis LeVee, Hannah Chang, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 9, 2025
New Drugs, New Toxicities: Side Effects of New and Emerging Breast Cancer TherapiesAlexis LeVee, Alana Deutsh, Ethan S Lindgren, et al.
Breast Cancer Research and Treatment|June 22, 2026
Receptor discordance between primary tumors and nodal metastases and correlation with the 21-gene recurrence score in early-stage, estrogen receptor-positive, node-positive breast cancerSerena Zheng, Peggy Sullivan, Kumkum Vadehra, et al.
Oncotargets and Therapy|September 23, 2021
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient SelectionAlexis LeVee, Ching Ying Lin, Edwin Posadas, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancers|July 12, 2025
Efficacy of Metastasis-Directed Radiation Therapy to Prolong Systemic Therapy for Patients with Oligoprogressive Metastatic Breast CancerAlexis LeVee, Hannah Young, Stephanie Yoon, et al.
The Oncologist|June 23, 2025
Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancerAlexis LeVee, Esther Peluso, Melissa G Lechner, et al.
Cancer Medicine|March 27, 2023
Incidence and prognostic impact of HER2-positivity loss after dual HER2-directed neoadjuvant therapy for HER2+ breast cancerAlexis LeVee, Kellie Spector, Brigid Larkin, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 10, 2026
Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment LandscapeMaeve A Hennessy, Elizabeth Terman, Damé Idossa, et al.
The Oncologist|November 9, 2025
Safety and clinical outcomes of pembrolizumab standard-interval dosing versus extended-interval dosing in patients with breast cancerAlexis LeVee, Austin Kordic, Nora Ruel, et al.
Breast Cancer Research and Treatment|May 28, 2026
Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy: a multi-institution studyAlexis LeVee, Bethania Santos, Megan Wong, et al.
Cancer Treatment and Research|August 23, 2025
Breast Cancer Immunotherapy: A Team Science ApproachMax Duesberg, Alexis LeVee, Hannah Chang, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 9, 2025
New Drugs, New Toxicities: Side Effects of New and Emerging Breast Cancer TherapiesAlexis LeVee, Alana Deutsh, Ethan S Lindgren, et al.
Breast Cancer Research and Treatment|June 22, 2026
Receptor discordance between primary tumors and nodal metastases and correlation with the 21-gene recurrence score in early-stage, estrogen receptor-positive, node-positive breast cancerSerena Zheng, Peggy Sullivan, Kumkum Vadehra, et al.
Oncotargets and Therapy|September 23, 2021
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient SelectionAlexis LeVee, Ching Ying Lin, Edwin Posadas, et al.
Pageof 3